PRESS RELEASE published on 02/08/2024 at 22:05, 2 years 3 months ago Applied DNA Announces First Quarter Fiscal Year 2024 Financial Results Applied DNA Sciences, Inc. (NASDAQ:APDN) announces Q1 fiscal year 2024 financial results and progress on GMP production capacity for mRNA therapeutics. Projects initial facility capacity to enable up to $15 million Linea IVT revenue annually Financial Results Applied DNA Sciences MRNA Therapeutics GMP Production Capacity Linea IVT Revenue
PRESS RELEASE published on 02/05/2024 at 19:00, 2 years 3 months ago Applied DNA to Report First Quarter Fiscal 2024 Financial Results on Thursday, February 8, 2024 Applied DNA Sciences, Inc. will release first quarter fiscal 2024 financial results after market close on February 8, 2024, with a conference call for analysts. The company operates in biotechnology developing DNA detection and production technologies Financial Results Conference Call Biotechnology Applied DNA Sciences DNA Detection
PRESS RELEASE published on 02/02/2024 at 22:15, 2 years 3 months ago Applied DNA Announces Closing of $3.44 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules Applied DNA Sciences, Inc. closes registered direct offering of common stock priced at-the-market with institutional investors. Proceeds to be used for therapeutic DNA production services Registered Direct Offering Institutional Investors Common Stock Applied DNA Sciences DNA Technologies
PRESS RELEASE published on 01/31/2024 at 14:00, 2 years 3 months ago Applied DNA Announces $3.44 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules Applied DNA Sciences, Inc. announces a registered direct offering and a concurrent private placement to certain existing institutional investors. Maxim Group LLC acts as exclusive placement agent Registered Direct Offering Applied DNA Sciences Securities Purchase Agreements Maxim Group LLC DNA Technologies
PRESS RELEASE published on 12/14/2023 at 14:00, 2 years 5 months ago Applied DNA Announces Joint Development Agreement to Integrate Linea(TM) IVT Platform into CDMO Kudo Biotechnology’s mRNA Manufacturing Workflow
PRESS RELEASE published on 12/07/2023 at 22:05, 2 years 5 months ago Applied DNA Announces Fourth Quarter Fiscal Year 2023 Financial Results
PRESS RELEASE published on 12/05/2023 at 14:30, 2 years 5 months ago Applied DNA to Report Fiscal 2023 Fourth Quarter and Year End Financial Results on December 7, 2023 Applied DNA Sciences, Inc. (NASDAQ:APDN) will release its Q4 and full year 2023 financial results on December 7, 2023, after the market close. A conference call for investors will follow to discuss the results Financial Results Conference Call Investor Relations Applied DNA Sciences NASDAQ:APDN
PRESS RELEASE published on 11/28/2023 at 14:30, 2 years 5 months ago Applied DNA Announces Receipt of Linea(TM) DNA Follow-On Order for Cancer Diagnostic Application
PRESS RELEASE published on 11/16/2023 at 14:30, 2 years 6 months ago Applied DNA Extends Application of Linea(TM) IVT Platform to saRNA (self-amplifying mRNA)
PRESS RELEASE published on 11/09/2023 at 15:15, 2 years 6 months ago Applied DNA Ships First saRNA (self-amplifying mRNA) IVT Template Generated by Linea(TM) DNA Platform
Published on 05/20/2026 at 15:28, 5 hours 27 minutes ago Sarama Resources Announces Private Equity Placement of A$1.5m
Published on 05/20/2026 at 15:01, 5 hours 54 minutes ago Kidoz Inc. Appoints Tarrnie Williams Jr. as Chief Operating Officer
Published on 05/20/2026 at 15:00, 5 hours 55 minutes ago BlackBerry Achieves FedRAMP Class D (High) Re-Certification as Government Demand for Mission-Critical Communications Grows
Published on 05/20/2026 at 14:00, 6 hours 55 minutes ago Ameriwest to Advance Its Bornite Copper Project by Re-Logging and Re-Assaying Historical Drill
Published on 05/20/2026 at 14:00, 6 hours 55 minutes ago First Canadian Graphite Reports Encouraging Results at Lac Guéret South from Airborne Survey Indicating Significant Expansion Possibilities
Published on 05/20/2026 at 20:15, 40 minutes ago EQS-Adhoc: AT&S Austria Technologie & Systemtechnik AG: AT&S expands capacity for AI substrates
Published on 05/20/2026 at 19:34, 1 hour 21 minutes ago CPIPG Communication Concerning Voluntary Offer on NEXT RE Shares – Final Results Announcement
Published on 05/20/2026 at 19:34, 1 hour 21 minutes ago EQS-Adhoc: AT&S Austria Technologie & Systemtechnik AG: AT&S intends to issue a (Hybrid) Convertible Bond and/or a Hybrid Bond; no dividend for the financial year 2025/26
Published on 05/20/2026 at 19:30, 1 hour 25 minutes ago Partners Group announces results of the 2026 Annual General Meeting of Shareholders
Published on 05/20/2026 at 18:00, 2 hours 55 minutes ago General shareholders meeting of 20 May, 2026
Published on 05/20/2026 at 17:45, 3 hours 10 minutes ago Report on share repurchases from 13 to 19 May 2026
Published on 05/20/2026 at 15:21, 5 hours 34 minutes ago Statement of transactions in own shares from May 11, 2026 to May 15, 2026
Published on 05/20/2026 at 08:30, 12 hours 25 minutes ago BMI Selects Actisure, the market-leading platform from Cegedim Insurance Solutions, to Power Health & Life Administration Across Latin America
Published on 05/20/2026 at 08:30, 12 hours 25 minutes ago EURAZEO ANNOUNCES THE FIRST CLOSE OF ITS PME V FUND AT OVER €1 BILLION, SEEDED WITH TWO INITIAL INVESTMENTS